1. Home
  2. CLPT vs ASPI Comparison

CLPT vs ASPI Comparison

Compare CLPT & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$9.15

Market Cap

467.9M

Sector

Health Care

ML Signal

HOLD

Logo ASP Isotopes Inc.

ASPI

ASP Isotopes Inc.

BUY

Current Price

$1.94

Market Cap

507.5M

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
CLPT
ASPI
Founded
1998
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
467.9M
507.5M
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
CLPT
ASPI
Price
$9.15
$1.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
★ $23.50
$13.00
AVG Volume (30 Days)
649.3K
★ 4.5M
Earning Date
10-28-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $36,971,000.00
$23,849,000.00
Revenue This Year
$32.54
N/A
Revenue Next Year
$15.41
$189.67
P/E Ratio
★ N/A
N/A
Revenue Growth
17.78
★ 475.48
52 Week Low
$8.27
$1.89
52 Week High
$27.27
$11.22

Technical Indicators

Market Signals
Indicator
CLPT
ASPI
Relative Strength Index (RSI) 31.63 28.21
Support Level $8.61 N/A
Resistance Level $15.30 $3.06
Average True Range (ATR) 0.48 0.19
MACD -0.01 -0.01
Stochastic Oscillator 5.20 4.50

Price Performance

Historical Comparison
CLPT
ASPI

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

About ASPI ASP Isotopes Inc.

ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.

Share on Social Networks: